DZ3048A1 - Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant. - Google Patents
Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant.Info
- Publication number
- DZ3048A1 DZ3048A1 DZ000092A DZ000092A DZ3048A1 DZ 3048 A1 DZ3048 A1 DZ 3048A1 DZ 000092 A DZ000092 A DZ 000092A DZ 000092 A DZ000092 A DZ 000092A DZ 3048 A1 DZ3048 A1 DZ 3048A1
- Authority
- DZ
- Algeria
- Prior art keywords
- atorvastine
- amlopidine
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13660899P | 1999-05-27 | 1999-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3048A1 true DZ3048A1 (fr) | 2004-03-27 |
Family
ID=22473579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ000092A DZ3048A1 (fr) | 1999-05-27 | 2000-05-24 | Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
Country Status (41)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT199800127A (es) * | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. | |
GB0027410D0 (en) * | 2000-11-09 | 2000-12-27 | Pfizer Ltd | Mutual prodrug of amlodipine and atorvastatin |
US6737430B2 (en) | 2000-11-09 | 2004-05-18 | Pfizer, Inc. | Mutual prodrug of amlodipine and atorvastatin |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
KR20040016882A (ko) * | 2001-06-11 | 2004-02-25 | 제노포트 인코포레이티드 | 감소된 독성을 가진 gaba 유사체 프로드러그의 구강투여용 투여 형태물 |
DE10140421A1 (de) * | 2001-08-17 | 2003-03-06 | Bayer Ag | Neue Kombination |
US7670612B2 (en) * | 2002-04-10 | 2010-03-02 | Innercap Technologies, Inc. | Multi-phase, multi-compartment capsular delivery apparatus and methods for using same |
US20040053842A1 (en) * | 2002-07-02 | 2004-03-18 | Pfizer Inc. | Methods of treatment with CETP inhibitors and antihypertensive agents |
US7071210B2 (en) * | 2002-07-02 | 2006-07-04 | Pfizer Inc. | CETP inhibitors in combination with antihypertensive agents and uses thereof |
CN102429882B (zh) | 2004-11-04 | 2015-03-25 | 什诺波特有限公司 | 加巴喷丁前体药物持续释放口服剂型 |
JP2009503075A (ja) * | 2005-08-01 | 2009-01-29 | シヴィダ・インコーポレイテッド | HMGCoA還元酵素インヒビターコドラッグ及びその使用 |
AR057882A1 (es) | 2005-11-09 | 2007-12-26 | Novartis Ag | Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra |
US8354116B2 (en) * | 2007-06-18 | 2013-01-15 | Biochemics, Inc. | Bifunctional synthetic molecules |
US8371336B2 (en) | 2007-10-10 | 2013-02-12 | Eagle Industry Co., Ltd. | Accumulator |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK161312C (da) | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
GB8608335D0 (en) | 1986-04-04 | 1986-05-08 | Pfizer Ltd | Pharmaceutically acceptable salts |
US4681893A (en) | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
US5155120A (en) | 1991-01-14 | 1992-10-13 | Pfizer Inc | Method for treating congestive heart failure |
GT199800127A (es) * | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. |
-
2000
- 2000-03-20 ES ES00911145T patent/ES2220426T3/es not_active Expired - Lifetime
- 2000-03-20 AU AU33139/00A patent/AU3313900A/en not_active Abandoned
- 2000-03-20 CA CA002375372A patent/CA2375372C/en not_active Expired - Fee Related
- 2000-03-20 PL PL00353483A patent/PL353483A1/xx not_active Application Discontinuation
- 2000-03-20 MX MXPA01012125A patent/MXPA01012125A/es active IP Right Grant
- 2000-03-20 EP EP00911145A patent/EP1180102B9/en not_active Expired - Lifetime
- 2000-03-20 BR BR0011006-0A patent/BR0011006A/pt not_active IP Right Cessation
- 2000-03-20 HU HU0201433A patent/HUP0201433A2/hu unknown
- 2000-03-20 CN CN00808081A patent/CN1352640A/zh active Pending
- 2000-03-20 EA EA200101130A patent/EA200101130A1/ru unknown
- 2000-03-20 JP JP2000621364A patent/JP2003500487A/ja active Pending
- 2000-03-20 AT AT00911145T patent/ATE268764T1/de not_active IP Right Cessation
- 2000-03-20 PT PT00911145T patent/PT1180102E/pt unknown
- 2000-03-20 TR TR2001/03391T patent/TR200103391T2/xx unknown
- 2000-03-20 AP APAP/P/2001/002345A patent/AP2001002345A0/en unknown
- 2000-03-20 DK DK00911145T patent/DK1180102T3/da active
- 2000-03-20 DE DE60011424T patent/DE60011424T2/de not_active Expired - Fee Related
- 2000-03-20 KR KR1020017015185A patent/KR20020012247A/ko not_active Application Discontinuation
- 2000-03-20 OA OA1200100312A patent/OA11950A/en unknown
- 2000-03-20 WO PCT/IB2000/000313 patent/WO2000073298A1/en active IP Right Grant
- 2000-03-20 CZ CZ20014229A patent/CZ20014229A3/cs unknown
- 2000-03-20 IL IL14594700A patent/IL145947A0/xx unknown
- 2000-03-20 SK SK1679-2001A patent/SK16792001A3/sk unknown
- 2000-03-20 EE EEP200100631A patent/EE200100631A/xx unknown
- 2000-05-17 HN HN2000000075A patent/HN2000000075A/es unknown
- 2000-05-19 PA PA20008495701A patent/PA8495701A1/es unknown
- 2000-05-24 US US09/577,561 patent/US6486182B1/en not_active Expired - Fee Related
- 2000-05-24 MA MA25986A patent/MA26736A1/fr unknown
- 2000-05-24 TN TNTNSN00113A patent/TNSN00113A1/fr unknown
- 2000-05-24 CO CO00038315A patent/CO5170457A1/es not_active Application Discontinuation
- 2000-05-24 DZ DZ000092A patent/DZ3048A1/xx active
- 2000-05-25 SV SV2000000082A patent/SV2002000082A/es not_active Application Discontinuation
- 2000-05-25 PE PE2000000498A patent/PE20010169A1/es not_active Application Discontinuation
- 2000-05-25 GT GT200000078A patent/GT200000078A/es unknown
- 2000-05-26 AR ARP000102581A patent/AR022344A1/es not_active Application Discontinuation
-
2001
- 2001-10-30 IS IS6135A patent/IS6135A/is unknown
- 2001-11-19 HR HR20010856A patent/HRP20010856A2/hr not_active Application Discontinuation
- 2001-11-26 NO NO20015756A patent/NO20015756L/no not_active Application Discontinuation
- 2001-11-26 ZA ZA200109691A patent/ZA200109691B/en unknown
- 2001-11-26 BG BG106149A patent/BG106149A/xx unknown
-
2002
- 2002-10-30 HK HK02107872.6A patent/HK1046282A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ3042A1 (fr) | Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2773A1 (fr) | Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2890A1 (fr) | 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ3020A1 (fr) | Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2581A1 (fr) | Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant. | |
DZ2745A1 (fr) | BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2523A1 (fr) | Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation. | |
DZ2758A1 (fr) | Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2963A1 (fr) | Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ3009A1 (fr) | Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ1889A1 (fr) | Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2303A1 (fr) | Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26659A1 (fr) | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
DZ2866A1 (fr) | 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2300A1 (fr) | Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2299A1 (fr) | Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2889A1 (fr) | 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant. | |
DZ2666A1 (fr) | Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
DZ2197A1 (fr) | Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ3038A1 (fr) | Modulateurs nouveaux des récepteurs de glucocorticoïdes, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ3048A1 (fr) | Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ3045A1 (fr) | Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2891A1 (fr) | Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2394A1 (fr) | Dérivés de quinoléine et dérivés de quinazoline nouveax procédé pour leur préparation et compositions pharmaceutiques les contenant | |
DZ1957A1 (fr) | Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. |